INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)
CUSIP: 45773H409
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 66,777,963
- Total 13F shares
- 10,168,502
- Share change
- -3,439,291
- Total reported value
- $20,694,831
- Put/Call ratio
- 30%
- Price per share
- $2.04
- Number of holders
- 101
- Value change
- -$6,577,397
- Number of buys
- 46
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45773H409:
Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
9.2%
|
3,633,333
|
$6,794,333 | $0 | 31 Dec 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.7%
|
3,119,162
|
$5,084,234 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1.5%
from 13D/G
|
2,318,480
|
$3,779,123 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
2,028,960
|
$3,307,206 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13D/G
13F
|
Company |
3.8%
|
1,434,997
|
$2,683,444 | -$900,721 | 31 Mar 2025 | |
| Jong Joseph Kim |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
3,113,086
mixed-class rows
|
$2,451,149 | — | 11 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2%
|
1,304,987
|
$2,127,130 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
846,803
|
$1,380,493 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.77%
|
514,148
|
$838,061 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
465,778
|
$759,219 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
284,643
|
$463,970 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.31%
|
207,867
|
$338,823 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.29%
|
194,371
|
$316,825 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
130,534
|
$212,770 | — | 31 Mar 2025 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.19%
|
126,119
|
$205,574 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.15%
|
103,297
|
$168,374 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.15%
|
100,675
|
$164,101 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
98,495
|
$160,547 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
75,422
|
$122,939 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
73,575
|
$119,926 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
72,364
|
$117,953 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.1%
|
66,169
|
$107,855 | — | 31 Mar 2025 | |
| Green Alpha Advisors, LLC |
13F
|
Company |
0.09%
|
61,261
|
$99,855 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.09%
|
56,806
|
$92,594 | — | 31 Mar 2025 | |
| Concurrent Investment Advisors, LLC |
13F
|
Company |
0.08%
|
55,011
|
$89,668 | — | 31 Mar 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.07%
|
46,836
|
$76,343 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.07%
|
45,828
|
$74,700 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
43,142
|
$70,321 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
41,699
|
$67,958 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
40,456
|
$66,101 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
39,025
|
$63,610 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
36,409
|
$59,347 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.06%
|
40,000
|
$58,400 | — | 31 Mar 2025 | |
| Simon X. Benito |
3/4/5
|
Director |
—
mixed-class rows
|
17,275
mixed-class rows
|
$51,120 | — | 21 May 2025 | |
| Prime Capital Investment Advisors, LLC |
13F
|
Company |
0.05%
|
30,299
|
$49,387 | — | 31 Mar 2025 | |
| Wendy L. Yarno |
3/4/5
|
Director |
—
mixed-class rows
|
15,596
mixed-class rows
|
$47,980 | — | 21 May 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.04%
|
29,375
|
$47,881 | — | 31 Mar 2025 | |
| Ann C. Miller |
3/4/5
|
Director |
—
mixed-class rows
|
14,961
mixed-class rows
|
$46,792 | — | 21 May 2025 | |
| Jay Shepard |
3/4/5
|
Director |
—
mixed-class rows
|
14,293
mixed-class rows
|
$45,543 | — | 21 May 2025 | |
| Roger D. Dansey |
3/4/5
|
Director |
—
mixed-class rows
|
14,000
mixed-class rows
|
$44,995 | — | 21 May 2025 | |
| Lota S. Zoth |
3/4/5
|
Director |
—
mixed-class rows
|
13,810
mixed-class rows
|
$44,640 | — | 21 May 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
25,042
|
$40,819 | — | 31 Mar 2025 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.04%
|
24,207
|
$39,457 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
22,369
|
$36,462 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
20,781
|
$33,873 | — | 31 Mar 2025 | |
| Freedom Investment Management, Inc. |
13F
|
Company |
0.03%
|
19,170
|
$31,247 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
18,441
|
$30,059 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
18,000
|
$29,340 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.03%
|
17,708
|
$28,864 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
17,631
|
$28,738 | — | 31 Mar 2025 |
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q2 2025
As of 30 Jun 2025,
INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,168,502 shares.
The largest 10 holders included
VANGUARD GROUP INC, Deep Track Capital, LP, BANK OF AMERICA CORP /DE/, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and UBS Group AG.
This page lists
102
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
105
Q2 2025 holders
101
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.